SCHEMBL19937543

SCHEMBL19937543

CCC(c1ccc(N2CCCC2)cc1)C(N)CF

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.39
▸ ALDH1A1 P00352 6/20 0.39
▸ NPC1 O15118 5/20 0.39
▸ RAB9A P51151 5/20 0.39
▸ KDM4E B2RXH2 4/20 0.39
▸ TP53 P04637 4/20 0.39
▸ NPSR1 Q6W5P4 3/20 0.39
▸ GAA P10253 3/20 0.39
▸ ALOX15 P16050 3/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ HTT P42858 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ KCNQ2 O43526 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19937529 0.81 USP2 (0.37) GAAUSP2SMN1; SMN2DPP4
SCHEMBL19937456 0.79 KDM4E (0.32) KDM4EGAA
SCHEMBL15628607 0.78 ALDH1A1 (0.38) MAPTALDH1A1NPC1RAB9AKDM4E
SCHEMBL15628457 0.77 ALDH1A1 (0.40) MAPTALDH1A1NPC1RAB9AKDM4E
SCHEMBL19937358 0.75 ESR1 (0.41) MAPTALDH1A1KDM4EALOX15HIF1A
SCHEMBL19937527 0.75 ESR1 (0.41) MAPTALDH1A1KDM4EGAAALOX15
SCHEMBL19937483 0.74 TDP1 (0.41) MAPTALDH1A1TP53ALOX15L3MBTL1
SCHEMBL19937478 0.72 ESR1 (0.38) MAPTALOX15TDP1LMNA
SCHEMBL14703927 0.72 ALDH1A1 (0.51) MAPTALDH1A1NPC1RAB9AKDM4E
SCHEMBL26039679 0.72 ALDH1A1 (0.47) MAPTALDH1A1NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3290427-A1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME Melinta Therapeutics, Inc. (US) 2018-03-07 — — EP disclosed
Send feedback